MD Medical Group Expands Operations to a New Region - Chelyabinsk
MD Medical Group IPJSC (“MD Medical”, “MDMG”, "Group" or the "Company"; MOEX: MDMG), a leading Russian private healthcare provider, announces the opening of its new clinic in Chelyabinsk.
Chelyabinsk, the eighth most populous city in Russia and the second largest cultural, economic, business, and political centre of the Urals, will now be home to the Mother & Child Chelyabinsk clinic. Spanning 420 sq m and centrally located, the facility will offer a wide range of specialised services for women in obstetrics, gynaecology, oncology, breast health, and reproductive medicine. Its offering will also encompass laboratory tests, ultrasound diagnostics, minor gynaecological surgeries, pregnancy planning and prenatal care, and IVF, including those covered by mandatory health insurance. In addition, patients will have access to consultations in such areas as therapy, cardiology, gastroenterology, endocrinology, genetics, and urology.
The new clinic is designed to accommodate 18,000 visits and 800 IVF cycles per year. Situated in leased premises, Mother & Child Chelyabinsk has received a total investment of RUB 105 million for its opening and outfitting, financed entirely through the Company’s own resources.
MDMG CEO Mark Kurtser said:
“Today, we opened the doors of our 61st healthcare facility, this time in the major industrial centre of the Urals – Chelyabinsk. It is crucial for us to provide high-quality medical care close to where the patients of this densely populated city live. We hope that our clinic, with its expertise in women's and reproductive health, will take a leading place among medical institutions in the Urals, contributing to the improvement of quality and accessibility of medical services in the region.”
About MD Medical Group
MD Medical Group is a leading provider in the highly attractive Russian private healthcare service market. Today, the Company manages 61 state-of-the-art healthcare facilities, including 11 multidisciplinary hospitals and 50 out-patient clinics in 30 regions of the Russian Federation. In 2023, MD Medical Group's revenue amounted to RUB 27.6 bln while EBITDA was RUB 9.2 bln. The Company's ordinary shares are traded on Moscow Exchange (MOEX: MDMG).